Cefuroxime 750 Mg Fksa, Cefuroxime 1 500 Mg Fksa 750 mg, 1 500 mg Powder for solution for Injection, Powder for solution for Injection or Infusion
PDF Leaflet Revision Date: 18 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible organisms.
Dosage (summary)
Adults: 750 mg to 1.5 g three times daily; adjust for renal impairment.
Onset of Action / Duration
Onset: 30-45 mins, Duration: 6-8 hours
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and breastfeeding not established.
Key Drug Interactions
- Aminoglycosides
- Diuretics
- Probenecid
Contraindications
- Hypersensitivity to cephalosporins
- Hypersensitivity to penicillins
Common side effects
- Neutropenia
- Eosinophilia
- Injection site reactions
Counselling Points
- Monitor for allergic reactions
- Report severe skin reactions immediately
Serious warnings
- Severe cutaneous adverse reactions
- Hypersensitivity reactions
Important Disclaimer
The Cefuroxime 750 Mg Fksa, Cefuroxime 1 500 Mg Fksa 750 mg, 1 500 mg Powder for solution for Injection, Powder for solution for Injection or Infusion professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
